cAMP-PDE signaling in COPD: Review of cellular, molecular and clinical features

cAMP-PDE signaling in COPD: Review of cellular, molecular and clinical features

Chronic obstructive pulmonary disease (COPD) is the fourth leading cause of death among non-contagious diseases in the world. PDE inhibitors are among current medicines prescribed for COPD treatment of which, PDE-4 family is the predominant PDE isoform involved in hydrolyzing cyclic adenosine monoph...

Full description

Bibliographic Details
Main Authors: Yazdan Hasani Nourian, Jafar Salimian, Ali Ahmadi, Zahra Salehi, Mehrdad Karimi, Alireza Emamvirdizadeh, Sadegh Azimzadeh Jamalkandi, Mostafa Ghanei
Format: Article
Language:English
Published: Elsevier 2023-07-01
Series:Biochemistry and Biophysics Reports
Subjects:
COPD Therapy
Phosphodiesterase inhibitors
cAMP signaling
Online Access:http://www.sciencedirect.com/science/article/pii/S2405580823000195

Internet

http://www.sciencedirect.com/science/article/pii/S2405580823000195

Similar Items